Tag: National Institutes of Health
January 16, 2019
Pain Therapeutics Awarded $1.5 Million Research Grant by National Institutes of Health
Pain Therapeutics (Nasdaq:PTIE), a clinical-stage drug development company, announced it has been awarded $1.5 million in research funding from the... May 9, 2018
Opiant Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results and Provides Corporate Update
Opiant Pharmaceuticals (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today reported financial results for the first quarter... April 30, 2018
Daré Bioscience announces funding award to further the development of Ovaprene
Daré Bioscience (NASDAQ:DARE), a clinical-stage, women’s biopharmaceutical company, today announced that it received a Notice of Award for the first $224,665 of...
April 29, 2018
Cannabis Weekly Round-Up: 3 New Cannabis Stocks Set to Launch in Canada
The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the... April 27, 2018
Cannabis Weekly Round-Up: 3 New Cannabis Stocks Set to Launch in Canada
The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
April 23, 2018
PUF Ventures Inc. – Dr. Cezar Khursigara, PhD Joins PUF Ventures Advisory Board
PUF Ventures Inc. (CSE:PUF, Frankfurt:PU3, OTCPK:PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased... April 18, 2018